| 标题 |
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Gay F; Musto P; Rota-Scalabrini D; Bertamini L; Belotti A; et al 出版日期:2021/12/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)